India has emerged as one of the world’s most reliable suppliers of pharmaceutical products, offering high-quality medicines, APIs, and medical devices at globally competitive standards. Over the last decade, pharmaceutical exports from India to Russia and CIS countries have grown significantly, driven by strong manufacturing capabilities, regulatory compliance, and cost efficiency.
Indian pharmaceutical manufacturers are known for adhering to WHO-GMP standards and supplying a wide range of generic formulations, biosimilars, and APIs. For Russian and CIS importers, India provides a dependable alternative supply source, especially for essential medicines, chronic therapy products, and hospital-use pharmaceuticals.
At GANGA-VOLGA, we act as a direct trade bridge between Indian manufacturers and buyers in Russia and CIS markets. Our sourcing model eliminates unnecessary intermediaries, ensuring better transparency, reliable documentation, and consistent supply. By combining regulatory understanding with export logistics expertise, we help our partners navigate cross-border pharmaceutical trade smoothly and confidently.
